Furthermore, KEGG enrichment analysis suggested that AGBL4-associated DEGs might participate in pathways related to microRNAs in human cancer and contribute to the IL-17 signaling pathway, which is frequently recognized as a reference index to judge the malignancy of gliomas (Figure 5C). This evidence concerns the gene IL17A and central nervous system cancer.